Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment
Clinical trial NCT07467330 · RECRUITING
Trial details
- NCT number
- NCT07467330
- Sponsor
- Fujian Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-15
- Primary completion
- 2031-12-31
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.